CLINICAL_TRIALS ClinicalTrials.gov record update

Validating The Prognostic Role of ATR Mutation in Patients With Endometrioid Endometrial Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01208467
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:27.257227+00:00
Published At: 2017-08-23T00:00:00+00:00
Record Updated At: 2017-08-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Endometrial Adenocarcinoma", "Recurrent Uterine Corpus Carcinoma", "Stage I Uterine Corpus Cancer", "Stage II Uterine Corpus Cancer", "Stage III Uterine Corpus Cancer", "Stage IV Uterine Corpus Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-08-23"
protocolSection.identificationModule.nctId: "NCT01208467"
protocolSection.identificationModule.officialTitle: "Validating The Prognostic Role of ATR Mutation in Patients With Endometrioid Endometrial Cancer"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.